CardioNet, a supplier of Mobile Cardiac Outpatient Telemetry (MCOT), provides next-generation ambulatory cardiac monitoring service with beat-to-beat, real time analysis, automatic arrhythmia detection and wireless ECG transmission.
The company's Director of Business Development Aaron Goldmuntz recently laid out his company’s growth strategy during a presentation at Qualcomm’s Smart Services Leadership Summit in July. Immediate opportunities for growth, Goldmuntz said, include leveraging CardioNet’s platform to develop additional applications that relate to atrial fibrillation. Adjacent markets could include work in clinical trials, increased business with cardiac surgeons, applications addressing stroke prevention as well as leveraging the CardioNet platform for use internationally.
Beyond those adjacent markets, Goldmuntz has also pointed to other conditions that CardioNet sees as potential opportunities for wireless diagnostic and monitoring tools, including: sleep apnea, hypertension, heart failure, diabetes and neurology.